TELA Bio (TELA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on TELA Bio (TELA) is Neutral.

The composite score behind that read is -0.06, weighing +0.05 of bullish evidence against -0.42 bearish.

TELA Bio last closed at $1.11, +5.71% on the session.

Against the IVW growth benchmark the position is +4.91% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for TELA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks TELA Bio in the 99th percentile on return on equity, where 100 is best.

TELA Bio is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $47.40M.

StockMap tracks TELA Bio as the 117th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite TELA Bio ranks 80th of 140 in the group, against a group median of -0.03.